ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 770,95
0,48%
Dow Jones
43 921,69
1,00%
DAX
21 042,00
0,18%
Brent Oil
78,795
-0,54%
Bitcoin
105 211,91
3,12%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Intra Cellular Therapies Inc (ITCI)

  7. Intra Cellular Therapies Inc (ITCI) Actualités

ITCI

Intra Cellular Therapies (ITCI)

Intra Cellular Therapies Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ITCI
DateHeureSourceTitreSymboleSociété
13/01/202523h27Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ITCIIntra Cellular Therapies Inc
13/01/202513h47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ITCIIntra Cellular Therapies Inc
13/01/202512h32GlobeNewswire Inc.Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.NASDAQ:ITCIIntra Cellular Therapies Inc
10/01/202512h30GlobeNewswire Inc.Intra-Cellular Therapies Settles CAPLYTA® (lumateperone) Patent Litigation with Sandoz NASDAQ:ITCIIntra Cellular Therapies Inc
06/01/202514h00GlobeNewswire Inc.Intra-Cellular Therapies to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ITCIIntra Cellular Therapies Inc
11/12/202414h00GlobeNewswire Inc.Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual MeetingNASDAQ:ITCIIntra Cellular Therapies Inc
07/12/202400h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
05/12/202422h27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
03/12/202413h30GlobeNewswire Inc.Intra-Cellular Therapies Submits Supplemental New Drug Application (sNDA) to FDA for CAPLYTA® (lumateperone) for the Treatment of Major Depressive Disorder as Adjunctive TherapyNASDAQ:ITCIIntra Cellular Therapies Inc
19/11/202414h00GlobeNewswire Inc.Intra-Cellular Therapies to Participate in Three Upcoming Investor ConferencesNASDAQ:ITCIIntra Cellular Therapies Inc
08/11/202423h31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ITCIIntra Cellular Therapies Inc
07/11/202414h00GlobeNewswire Inc.Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI CongressNASDAQ:ITCIIntra Cellular Therapies Inc
05/11/202413h00GlobeNewswire Inc.Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with SchizophreniaNASDAQ:ITCIIntra Cellular Therapies Inc
30/10/202412h53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ITCIIntra Cellular Therapies Inc
30/10/202412h30GlobeNewswire Inc.Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales GuidanceNASDAQ:ITCIIntra Cellular Therapies Inc
17/10/202414h00GlobeNewswire Inc.Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and WebcastNASDAQ:ITCIIntra Cellular Therapies Inc
23/09/202414h00GlobeNewswire Inc.Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology CongressNASDAQ:ITCIIntra Cellular Therapies Inc
28/08/202414h00GlobeNewswire Inc.Intra-Cellular Therapies to Present at Three Upcoming Investor ConferencesNASDAQ:ITCIIntra Cellular Therapies Inc
15/08/202400h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
08/08/202414h00GlobeNewswire Inc.Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:ITCIIntra Cellular Therapies Inc
07/08/202413h40GlobeNewswire Inc.Intra-Cellular Therapies Announces Appointment of Sanjeev Narula as Chief Financial OfficerNASDAQ:ITCIIntra Cellular Therapies Inc
07/08/202413h30GlobeNewswire Inc.Intra-Cellular Therapies Reports Second Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 CAPLYTA Sales GuidanceNASDAQ:ITCIIntra Cellular Therapies Inc
24/07/202414h00GlobeNewswire Inc.Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and WebcastNASDAQ:ITCIIntra Cellular Therapies Inc
18/06/202413h30GlobeNewswire Inc.Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive DisorderNASDAQ:ITCIIntra Cellular Therapies Inc
10/06/202414h00GlobeNewswire Inc.Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare ConferenceNASDAQ:ITCIIntra Cellular Therapies Inc
29/05/202414h00GlobeNewswire Inc.Intra-Cellular Therapies to Present at the Jefferies Global Healthcare ConferenceNASDAQ:ITCIIntra Cellular Therapies Inc
23/05/202414h00GlobeNewswire Inc.Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual MeetingNASDAQ:ITCIIntra Cellular Therapies Inc
08/05/202414h00GlobeNewswire Inc.Intra-Cellular Therapies to Participate in Two Upcoming Investor ConferencesNASDAQ:ITCIIntra Cellular Therapies Inc
07/05/202413h30GlobeNewswire Inc.Intra-Cellular Therapies Reports First Quarter 2024 Financial ResultsNASDAQ:ITCIIntra Cellular Therapies Inc
30/04/202414h00GlobeNewswire Inc.Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and WebcastNASDAQ:ITCIIntra Cellular Therapies Inc
 Showing the most relevant articles for your search:NASDAQ:ITCI

Dernières Valeurs Consultées

EU
BEL20
Bel 20
EU
VK
Vallourec
EU
SGO
Cie de SaintGobain
EU
ML
Michelin
COIN
DOGEUSD
Dogecoin
NYSE
KO
Coca Cola
EU
AI
Air Liquide
EU
BN
Danone
EU
ORA
Orange
NASDAQ
MSFT
Microsoft
EU
GLE
Societe Generale
NASDAQ
GOOGL
Alphabet
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés